Capricor Therapeutics, Inc.
US ˙ NasdaqGS ˙ US14070B3096

SecurityCAPR / Capricor Therapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in CAPR / Capricor Therapeutics, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Capricor Therapeutics, Inc. (US:CAPR) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 19,063 shares of Capricor Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (CAPR) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CAPR / Capricor Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -19,063 -100.00 0 -100.00
2025-11-12 2025-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 19,063 19,063 137 0.0002
2025-08-14 2025-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -55,049 -100.00 0 -100.00
2025-05-14 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 55,049 48,838 786.31 522 514.12 0.0015
2025-05-14 2024-12-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 6,211 6,211 86 0.0002
2025-02-14 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 6,211 6,211 86 0.0002
2024-11-14 2024-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -11,695 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 11,695 11,695 56 0.0002
2024-05-10 2024-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -2,006 -100.00 0 -100.00
2024-02-14 2023-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 2,006 -33,962 -94.42 10 -92.68 0.0000
2023-11-09 2023-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 35,968 9,300 34.87 123 -3.15 0.0004
2023-08-09 2023-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 26,668 -673 -2.46 127 10.43 0.0004
2023-05-12 2023-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 27,341 4,295 18.64 115 30.68 0.0004
2023-02-09 2022-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 23,046 -22,886 -49.83 89 -68.12 0.0002
2022-11-09 2022-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 45,932 -7,846 -14.59 276 46.81 0.0005
2022-08-11 2022-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 53,778 20,922 63.68 188 66.37 0.0003
2022-05-12 2022-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 32,856 10,285 45.57 113 71.21 0.0001
2022-02-11 2021-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 22,571 3,388 17.66 66 -14.29 0.0001
2021-11-12 2021-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 19,183 -55,168 -74.20 77 -79.79 0.0001
2021-08-10 2021-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 74,351 33,262 80.95 381 98.44 0.0005
2021-05-12 2021-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 41,089 41,089 192 0.0003
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 467,800 145.05 13,501 881.10 n/a n/a n/a
2025-11-12 2025-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 190,900 -20.79 1,376 -42.50 n/a n/a n/a
2025-08-14 2025-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 241,000 107.22 2,393 116.95 n/a n/a n/a
2025-05-14 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 116,300 7.19 1,104 -26.32 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CAPRICOR THERAPEUTICS COM NEW Put 108,500 81.74 1,497 64.87 n/a n/a n/a
2025-02-14 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 108,500 1,497 n/a n/a n/a
2024-11-14 2024-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 59,700 610.71 908 2,170.00 n/a n/a n/a
2024-08-14 2024-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 8,400 663.64 40 471.43 n/a n/a n/a
2024-05-10 2024-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 1,100 -72.50 7 -63.16 n/a n/a n/a
2024-02-14 2023-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 4,000 25.00 20 90.00 n/a n/a n/a
2023-11-09 2023-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 3,200 -64.44 11 -76.74 n/a n/a n/a
2023-08-09 2023-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 9,000 -38.78 43 -30.65 n/a n/a n/a
2023-05-12 2023-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 14,700 -34.67 62 -27.91 n/a n/a n/a
2023-02-09 2022-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 22,500 -21.05 87 -49.71 n/a n/a n/a
2022-11-09 2022-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 28,500 9.20 171 87.91 n/a n/a n/a
2022-08-11 2022-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 26,100 110.48 91 111.63 n/a n/a n/a
2022-05-12 2022-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 12,400 -22.98 43 -8.51 n/a n/a n/a
2022-02-11 2021-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 16,100 -54.65 47 -67.13 n/a n/a n/a
2021-11-12 2021-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 35,500 -61.91 143 -70.08 n/a n/a n/a
2021-08-10 2021-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 93,200 143.98 478 167.04 n/a n/a n/a
2021-05-12 2021-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 38,200 3,372.73 179 4,375.00 n/a n/a n/a
2021-02-10 2020-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 1,100 -83.33 4 -88.57 n/a n/a n/a
2020-11-12 2020-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 6,600 2,100.00 35 3,400.00 n/a n/a n/a
2020-08-13 2020-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 300 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.